Kingdon Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-20,000
Closed -$97K 152
2016
Q4
$97K Sell
20,000
-13,100
-40% -$389K ﹤0.01% 123
2016
Q3
$1.53M Buy
+33,100
New +$1.87M 0.07% 107

Kingdon Capital Management's ISEE Position: Q3 2023 in Review

Kingdon Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 980,050 shares — an estimated $38.6M sold.

Kingdon Capital Management first reported a position in ISEE in Q4 2022 and held it in 3 quarters. The position peaked at $38.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Kingdon Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Kingdon Capital Management sold 980,050 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $38.6M.
  • Kingdon Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Kingdon Capital Management's IVERIC bio, Inc. Common Stock position peaked at $38.6M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Kingdon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.